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The 17th Ecco -38th ESMo -32nd ESTRo European cancer congress, in amsterdam from 27 September to 1 october 2013, will once again combine the united efforts of all partner organisations to continue positioning multidisciplinarity as the way forwards to best improve the prevention, diagnosis, treatment and care of cancer patients.
The recognised multidisciplinary setting of the congress, involving seven oncology organisations: the European cancer organisation (Ecco), the European Society for Medical oncology (ESMo), the European Society for Therapeutic Radiology and oncology (ESTRo), the European association for cancer Research (EacR), the European Society of Surgical oncology (ESSo), the European oncology Nursing Society (EoNS) and the European Society for Pediatric oncology (SioPE), will provide ideal surroundings for participants to leverage knowledge, promote education and build awareness about oncology -placing the patient at the heart of all efforts and discussions. Thanks to this multidisciplinary collaboration, oncology professionals and patient advocates alike are able to see and learn from the tangible benefits of cancer disciplines working together.
Featuring the strongest and most forward-focused scientific programme to date, the 33 tracks span the entire oncology spectrum to showcase the latest developments in practice-changing studies of new and significant importance in oncology, guaranteeing a multiprofessional, multidisciplinary appeal. The European cancer congresses are the only multidisciplinary and multiprofessional educational meetings in oncology to take place in Europe -a fact that underpins the relevance, role and participation of each and every specialty in oncology.
Opening Ceremony
There is an exciting line-up of top experts in their fields participating at the opening event. a special guest lecture will be given by Suzanne Topalian at the opening ceremony. She is a renowned surgical oncologist with 21 years of experience at the Surgery Branch of the National cancer institute. her talk is entitled: 'Mobilising the immune System to Treat cancer'. at the opening Session, hans clevers will be discussing 'lgr5 Stem cells in self-renewal and cancer'; Bill Sellers will be focusing on 'The genetic basis for cancer therapy -the opportunity and the challenges' and charlie Swanton will look at 'intratumour heterogeneity and cancer evolution'.
Scientific Programme
This congress will play a pivotal role in establishing standards for the 
Other Programme Highlights
Modern medicine has to a large extent been transformed by tremendous developments witnessed within industry and technology, as well as cancer management and research in recent decades. That is why the late-breaking abstracts will form the core of the presidential Sessions in amsterdam, as well as featuring in proffered paper sessions. the number of oral presentation slots has increased to provide a leading showcase for these latest developments in practice-changing studies of new and significant scientific importance. these data will help accelerate the promise of personalised medicine, impact directly on our patients through more effective prevention strategies, earlier diagnosis and better treatment modalities, as well as succeed in bringing cuttingedge data back to Europe. a comprehensive, stimulating, rigorous and highly educational scientific experience, irrespective of participants' roles or focus in oncology is guaranteed for all participants. the 17th Ecco, 38th ESmo, 32nd EStro European cancer congress forms the foremost milestone on the world congress agenda in progressing the fight against cancer through the multidisciplinary approach. n Special Report
